Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Geoffrey Kim

Showing results (11-20 of 29) with videos related to

Pageof 3
Sort By:
Nature Communications|July 27, 2022
Decoding kinase-adverse event associations for small molecule kinase inhibitorsXiajing Gong, Meng Hu, Jinzhong Liu, et al.
The Oncologist|June 14, 2015
U.S. Food and Drug Administration Approval Summary: Enzalutamide for the Treatment of Patients With Chemotherapy-Naïve Metastatic Castration-Resistant Prostate CancerYang-Min Ning, Michael Brave, V Ellen Maher, et al.
JACC. Basic to Translational Science|July 18, 2017
21st Century Cardio-Oncology: Identifying Cardiac Safety Signals in the Era of Personalized MedicineCalvin Chen Sheng, Laleh Amiri-Kordestani, Todd Palmby, et al.
Oncoimmunology|September 16, 2020
Dose dependence of treatment-related adverse events for immune checkpoint inhibitor therapies: a model-based meta-analysisBoris Shulgin, Yuri Kosinsky, Andrey Omelchenko, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 17, 2015
Expansion Cohorts in First-in-Human Solid Tumor Oncology TrialsMarc R Theoret, Lee H Pai-Scherf, Meredith K Chuk, et al.
NPJ Precision Oncology|November 17, 2024
Deep learning for oncologic treatment outcomes and endpoints evaluation from CT scans in liver cancerYujia Xia, Jie Zhou, Xiaolei Xun, et al.
The Oncologist|April 21, 2017
FDA Approval Summary: Atezolizumab for the Treatment of Patients with Progressive Advanced Urothelial Carcinoma after Platinum-Containing ChemotherapyYang-Min Ning, Daniel Suzman, V Ellen Maher, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 10, 2018
US Food and Drug Administration Pooled Analysis to Assess the Impact of Bone-Only Metastatic Breast Cancer on Clinical Trial Outcomes and Radiographic AssessmentsSuparna B Wedam, Julia A Beaver, Laleh Amiri-Kordestani, et al.
The Lancet Regional Health. Southeast Asia|May 17, 2024
Landscape of cancer clinical trials in India - a comprehensive analysis of the Clinical Trial Registry-IndiaPeng Gao, Justin Chen, Zhongyu Hong, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 14, 2016
Focusing on Core Patient-Reported Outcomes in Cancer Clinical Trials: Symptomatic Adverse Events, Physical Function, and Disease-Related SymptomsPaul G Kluetz, Ashley Slagle, Elektra J Papadopoulos, et al.
Pageof 3

Showing results (11-20 of 29) with videos related to

Sort By:
Pageof 3
Nature Communications|July 27, 2022
Decoding kinase-adverse event associations for small molecule kinase inhibitorsXiajing Gong, Meng Hu, Jinzhong Liu, et al.
The Oncologist|June 14, 2015
U.S. Food and Drug Administration Approval Summary: Enzalutamide for the Treatment of Patients With Chemotherapy-Naïve Metastatic Castration-Resistant Prostate CancerYang-Min Ning, Michael Brave, V Ellen Maher, et al.
JACC. Basic to Translational Science|July 18, 2017
21st Century Cardio-Oncology: Identifying Cardiac Safety Signals in the Era of Personalized MedicineCalvin Chen Sheng, Laleh Amiri-Kordestani, Todd Palmby, et al.
Oncoimmunology|September 16, 2020
Dose dependence of treatment-related adverse events for immune checkpoint inhibitor therapies: a model-based meta-analysisBoris Shulgin, Yuri Kosinsky, Andrey Omelchenko, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 17, 2015
Expansion Cohorts in First-in-Human Solid Tumor Oncology TrialsMarc R Theoret, Lee H Pai-Scherf, Meredith K Chuk, et al.
NPJ Precision Oncology|November 17, 2024
Deep learning for oncologic treatment outcomes and endpoints evaluation from CT scans in liver cancerYujia Xia, Jie Zhou, Xiaolei Xun, et al.
The Oncologist|April 21, 2017
FDA Approval Summary: Atezolizumab for the Treatment of Patients with Progressive Advanced Urothelial Carcinoma after Platinum-Containing ChemotherapyYang-Min Ning, Daniel Suzman, V Ellen Maher, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 10, 2018
US Food and Drug Administration Pooled Analysis to Assess the Impact of Bone-Only Metastatic Breast Cancer on Clinical Trial Outcomes and Radiographic AssessmentsSuparna B Wedam, Julia A Beaver, Laleh Amiri-Kordestani, et al.
The Lancet Regional Health. Southeast Asia|May 17, 2024
Landscape of cancer clinical trials in India - a comprehensive analysis of the Clinical Trial Registry-IndiaPeng Gao, Justin Chen, Zhongyu Hong, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 14, 2016
Focusing on Core Patient-Reported Outcomes in Cancer Clinical Trials: Symptomatic Adverse Events, Physical Function, and Disease-Related SymptomsPaul G Kluetz, Ashley Slagle, Elektra J Papadopoulos, et al.
Pageof 3